15:05:49 RRSAgent has joined #hcls 15:05:49 logging to http://www.w3.org/2008/10/15-hcls-irc 15:06:17 Zakim, this is hcls 15:06:17 ericP, this was already SW_HCLS()11:00AM 15:06:18 ok, ericP; that matches SW_HCLS()11:00AM 15:07:05 Meeting: Scientific Discourse 15:07:16 scribenic: Donald_Doherty 15:07:17 [Susie] Agenda 15:07:35 [Susie] Literature search 15:08:00 -> http://esw.w3.org/topic/HCLSIG/LODD/Literature literature 15:08:53 -> http://mor.nlm.nih.gov/pubs/pdf/2008-amia-ms.pdf Recommended paper 15:08:54 [Susie] Compiled a good list. Especially relevant is "A framework for characterizing drug information sources" 15:11:31 Paper has very useful table with 39 dimensions of drug sources. 15:12:37 [Susie] Bio2RDF and LarKC papers have a lot of relevance. 15:13:05 [Susie] We can invite people who have done relevant work to speak on our call. 15:13:30 Susie: Bio2RDF and LarKC papers have a lot of relevance. 15:13:36 ... We can invite people who have done relevant work to speak on our call. 15:15:18 topic: Summary of Bio2RDF [ChrisB] 15:15:33 Chris: Invite Bio2RDF people talk 15:16:42 ...They're running into interesting problems of scalability. 15:17:55 ... Their goal is to bring together as much data as they can and then find use cases. 15:18:10 Susie: Interesting that they're taking opposite approach as us. 15:18:48 Spoke about use cases yesterday with Kei 15:19:07 ... We have F2F next week. During breakout sessions we'll do work on use cases. 15:19:52 ... We should define a use case that would be useful for both pharmaceutical companies and physicians. 15:20:01 ... Scope use case to therapeutic area. 15:20:49 ... One thought was respiratory diseases 15:21:12 ... However neuroscience will be focus as long as it can be extended to respiratory 15:21:41 ... Interested in co-morbitity. Drug targeting multiple diseases, etc. 15:21:57 ... Nice to have links that go from drugs to disease. 15:23:02 -> http://esw.w3.org/topic/HCLSIG/LODD/Business Business case 15:23:05 ... also links from drug to disease to biology to symptoms. 15:23:32 ... Good to use clinicaltrials.gov data. 15:24:20 ... Interest from three actors: patients, physicians, pharma 15:24:54 ... Defined what sorts of questions patients ask. 15:25:26 ... For instance "What other drugs are available for this disease?" 15:25:46 ... Defined what sorts of questions physicians ask. 15:26:31 ... Wondered if we could link to COI work. 15:26:48 ... Defined sorts of questions phara would ask. 15:27:47 ... Pharma want to ask a lot of bio questions related to drugs. 15:28:00 ... These questions would link into BioRDF work. 15:28:45 Oktie: I'm currently working on the clinicaltrials.gov data 15:29:24 ... We're working on algorithms on finding links among data. We haven't published yet. Within about a month we'll have something ready. 15:32:34 Oktie: action to go back to his group to see about publishing data 15:33:29 Susie: Will continue discussions with Bosse next week 15:35:02 Eric: Do you expect this data set to touch identifiers that NCBI will serve? 15:36:14 Susie: Talk about hosting workshop at NIH during Jan./Feb. timeframe dealing with URIs 15:37:56 Sound quality is very bad! 15:38:13 Good! 15:40:24 Oktie: Use cases go back to the idea of linked data. Wonder if we should publish linked data even if we have no use case. 15:41:29 Chris: I see no problem with the idea. 15:41:47 Susie: Same here. However, it is important to be able to show 15:41:53 ... the value of what we've done. 15:42:22 ... Chris sent an email to the main list about a special issue of linked data and SW. 15:42:38 ... I'd like to see us submit a paper. 15:42:46 -> http://linkeddata.org/docs/ijswis-special-issue IJSWIS special issue on linked data 15:43:18 Susie: Data set exploration 15:43:35 -> http://esw.w3.org/topic/HCLSIG/LODD/Data/DataSetEvaluation Data set evaluation 15:43:42 Chris: Two tables. One table has a list of data already available. 15:44:32 ... the other table has a list that are not yet available as linked data. 15:47:46 Susie: Focus on something general and then perhaps bring specific company data set in. 15:48:40 ... Idea of developing a cloud sounds really good. 15:50:30 ... At Lilly I'm trying to create a high-level ontology linking areas related to bio related to disease, market opportunity, clinical trials, etc. Drugs could be a component. 15:51:05 ... Chris what are you thinking about for browsers, visualization tools... 15:51:32 Chris: You can use all different browsers to pick up data. 15:52:46 ... We could go to the LSID browser... 15:53:12 Susie: There have been URI/LSID wars. 15:53:54 ... prefer to use URIs. 15:54:24 Chris: The linked data must be HTTP based. 15:56:43 -> http://esw.w3.org/topic/HCLSIG/F2F/2008-10_F2F F2F URL 15:57:47 Susie: Good progress! See you in 2 weeks. 15:57:50 -[IBM] 15:57:51 - +0049308385aabb 15:57:51 -Susie 15:57:52 - +049308385aaaa 15:57:57 -EricP 15:58:05 -Don_Doherty 15:58:06 SW_HCLS()11:00AM has ended 15:58:07 Attendees were +049308385aaaa, Susie, +0049308385aabb, Don_Doherty, EricP, [IBM] 15:58:15 Eric... are you publishing this for me? 15:58:32 RRSAgent, please draft minutes 15:58:32 I have made the request to generate http://www.w3.org/2008/10/15-hcls-minutes.html ericP 15:58:40 RRSAgent, please make log world-visible 15:58:45 Thank you! :^) 15:58:57 np. my fingers are programmed 17:14:22 Zakim has left #hcls 18:53:11 holger_stenzhorn has joined #hcls 18:57:51 mkennedy has joined #hcls 19:07:55 mkennedy has joined #hcls 19:08:41 mkennedy has joined #hcls 19:20:29 holger_stenzhorn has left #hcls